Key statistics
On Friday, Calidi Biotherapeutics Inc (CLDI:ASQ) closed at 2.14, 193.15% above the 52 week low of 0.73 set on Oct 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.12 |
---|---|
High | 2.20 |
Low | 1.96 |
Bid | 2.07 |
Offer | 2.15 |
Previous close | 2.15 |
Average volume | 4.92m |
---|---|
Shares outstanding | 17.52m |
Free float | 15.40m |
P/E (TTM) | -- |
Market cap | 37.66m USD |
EPS (TTM) | -5.61 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 23:30 GMT.
More ▼
- Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
- Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock
- Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock
- Calidi Biotherapeutics Announces Proposed Public Offering
- Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results
- Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
- Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
- NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
- Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
- Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
More ▼